Mr. Eutillio Buccilli Chief Executive Officer Genetic Technologies LimitedGenetic Technologies LTD • December 2nd, 2016 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 2nd, 2016 Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 2nd, 2016 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 2nd, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of December 1, 2016 is between Genetic Technologies Limited ACN 009 212 328 of 60-66 Hanover Street, Fitzroy VIC 3065, an Australian public company incorporated under the laws of Western Australia in the Commonwealth of Australia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).